Studies on the significance of bioactive gangliosides in cellular growth and differntiation.

生物活性神经节苷脂在细胞生长和分化中的意义的研究。

基本信息

  • 批准号:
    60440102
  • 负责人:
  • 金额:
    $ 15.49万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
  • 财政年份:
    1985
  • 资助国家:
    日本
  • 起止时间:
    1985 至 1988
  • 项目状态:
    已结题

项目摘要

Carbohydrate recognition at cell surface is known to importantly be involved in cell to cell interactions, cell growth and differentiation.Most of such modulatory potentials have so far been reported on a family of sialylated glycosphingolipids, gangliosides, using cultured cell system added with these glycolipids exogenously. We previously reported that a disialoganglioside GD3 strongly promotes ions and water transport in cultured kidney epithelial cells (MDCK). Newly and specific appearance of GD3 was observed in rat embryonic fibroblastic cells, 3Y1, which were transfected and transformed with various oncogenes of DNA-virus origin (adenovirus E1A, SV40-T and myc). The monoclonal antibody to GD3 reversibly inhibits cell growth of these cells. The remarkable elevation of GD3 was reported on neuron and glial cells in their proliferative states. More recently we have found that a tetrasialoganglioside G 1b specifically can promote differentiation of the human neuroblastoma cells, leading to the promotion of neuritogenesis and also that G 1b specifically stimulates the phosphorylation of several cell surface proteins of the same cells, when the G 1b and ATP are added to the cells. The results indicate that this cell surface protein phosphorylation might be carried out by unique cell surface membrane protein kinase(s) (ecto-Gg kinase) which is specifically activated by a particular ganglioside. Inhibition of this phosphorylation resulted in the inhibition of G 1b-dependent promotion of neuritogenesis, strongly suggesting the interrelationship between those two cell events and occurrence of a new biosignal transduction, ecto biosignal transduction system.
糖分子在细胞表面的识别与细胞间的相互作用、细胞的生长和分化密切相关,目前已报道的糖分子识别调控机制主要是通过在细胞培养体系中外源性添加糖脂类化合物神经节苷脂来实现的。我们以前报道过,一个disialoganglioside GD 3强烈促进离子和水的运输在培养的肾上皮细胞(MDCK)。在大鼠胚胎成纤维细胞3 Y1中观察到GD 3的新的和特异性的出现,该细胞用DNA病毒来源的各种癌基因(腺病毒E1 A、SV 40-T和myc)转染并转化。GD 3的单克隆抗体可逆地抑制这些细胞的细胞生长。GD 3的显着升高的神经元和神经胶质细胞在其增殖状态。最近,我们发现四唾液酸神经节苷脂G1 b可以特异性地促进人神经母细胞瘤细胞的分化,从而促进神经突的发生,并且当G1 b和ATP被添加到细胞中时,G1 b还特异性地刺激相同细胞的几种细胞表面蛋白的磷酸化。结果表明,这种细胞表面蛋白磷酸化可能是由独特的细胞表面膜蛋白激酶(外-Gg激酶)进行的,该激酶被特定的神经节苷脂特异性激活。这种磷酸化的抑制导致抑制G1 b依赖的促进轴突发生,强烈表明这两个细胞事件之间的相互关系和发生一个新的生物信号转导,外生物信号转导系统。

项目成果

期刊论文数量(48)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
S.Kosugi: Biochem.Biophys.Res.Commun.143. 848-855 (1987)
S.Kosugi:Biochem.Biophys.Res.Commun.143。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Tsuji: "Bioactive gangliosides. IV. ganglioside GQlb/Ca^<2+> dependent protein kinase activity exists in the plasma membrane fraction of neuroblastoma cell line, GOTO." J. Biochem.97. 969-972 (1985)
S.Tsuji:“生物活性神经节苷脂。IV.神经母细胞瘤细胞系GOTO的质膜部分中存在神经节苷脂GQlb/Ca^2依赖性蛋白激酶活性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
J.Nakajima: "Bioactive gangliosides: analysis of functional structures of the tetrasialoganglioside GQlb which promotes neurite outgrowth." Biochim. Biophys. Acta. 876. 65-71 (1986)
J.Nakajima:“生物活性神经节苷脂:促进神经突生长的四唾液酸神经节苷脂 GQlb 的功能结构分析。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H.Nakaishi: "Analysis of cellular expression of gangliosides by gene transfection I: GD3 expression in myc-transfected and transformed 3Y1 correlates anchorage-independent growth activity." Biochem. Biophys. Res. Commun.150. 760-765 (1988)
H.Nakaishi:“通过基因转染对神经节苷脂的细胞表达进行分析 I:myc 转染和转化的 3Y1 中的 GD3 表达与锚定无关的生长活性相关。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Nagai: Bioactive gangliosides: A new type of biologically active cell membrane compounds. in "Natural products and biological activities". University of Tokyo Press, 153-165 (1986)
Y.Nagai:生物活性神经节苷脂:一种新型的生物活性细胞膜化合物。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAGAI Yoshitaka其他文献

NAGAI Yoshitaka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAGAI Yoshitaka', 18)}}的其他基金

Establishment and pathological analyses of transgenic marmoset models of polyglutamine diseases
转基因狨猴多聚谷氨酰胺病模型的建立及病理分析
  • 批准号:
    26670446
  • 财政年份:
    2014
  • 资助金额:
    $ 15.49万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
A gain of toxic function hypothesis via accumulated RNA-binding protein and repeat RNA in the pathogenesis of ALS and its validation in vivo
通过积累的RNA结合蛋白和重复RNA在ALS发病机制中获得毒性功能假说及其体内验证
  • 批准号:
    24659438
  • 财政年份:
    2012
  • 资助金额:
    $ 15.49万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Therapeutic strategy for the polyglutamine diseases by selective degradation of expanded polyglutamine proteins using polyglutamine-binding pepetides
使用多聚谷氨酰胺结合肽选择性降解扩展的多聚谷氨酰胺蛋白来治疗多聚谷氨酰胺疾病
  • 批准号:
    23390237
  • 财政年份:
    2011
  • 资助金额:
    $ 15.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a drug for the polyglutamine diseases by molecular design of chemical analogues of the aggregation inhibitor peptide QBP1
通过聚集抑制肽 QBP1 化学类似物的分子设计开发治疗多聚谷氨酰胺疾病的药物
  • 批准号:
    22659172
  • 财政年份:
    2010
  • 资助金额:
    $ 15.49万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Molecular therapy for the polyglutamine diseases targeting the toxic β-sheet conformers and oligomers
针对有毒β-折叠构象异构体和寡聚物的聚谷氨酰胺疾病的分子治疗
  • 批准号:
    20390245
  • 财政年份:
    2008
  • 资助金额:
    $ 15.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Screening for modifier genes of polyglutamine-induced neuronal dysfunction using a Drosophila polyglutamine disease model.
使用果蝇多谷氨酰胺疾病模型筛选多谷氨酰胺诱导的神经元功能障碍的修饰基因。
  • 批准号:
    17590875
  • 财政年份:
    2005
  • 资助金额:
    $ 15.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of a molecular therapy for neurodegenerative diseases including the polyglutamine diseases.
建立针对神经退行性疾病(包括多聚谷氨酰胺疾病)的分子疗法。
  • 批准号:
    14570594
  • 财政年份:
    2002
  • 资助金额:
    $ 15.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of glycolipid expression and its disorder
糖脂表达的调控及其紊乱
  • 批准号:
    03454157
  • 财政年份:
    1991
  • 资助金额:
    $ 15.49万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Signal Transduction of Bioactive Carbohydrate Chains and Their Genetic Expression
生物活性碳水化合物链的信号转导及其基因表达
  • 批准号:
    01440091
  • 财政年份:
    1989
  • 资助金额:
    $ 15.49万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)

相似海外基金

Protein Phosphorylation Networks in Health and Disease
健康和疾病中的蛋白质磷酸化网络
  • 批准号:
    10682983
  • 财政年份:
    2023
  • 资助金额:
    $ 15.49万
  • 项目类别:
NSF-BSF: The role of protein phosphorylation in the mitochondrial matrix in determining mitophagic selectivity
NSF-BSF:线粒体基质中蛋白质磷酸化在确定线粒体自噬选择性中的作用
  • 批准号:
    2327631
  • 财政年份:
    2023
  • 资助金额:
    $ 15.49万
  • 项目类别:
    Standard Grant
Protein phosphorylation and Campylobacter jejuni pathogenesis
蛋白质磷酸化和空肠弯曲菌发病机制
  • 批准号:
    10608212
  • 财政年份:
    2022
  • 资助金额:
    $ 15.49万
  • 项目类别:
Novel roles of PDK4 in regulating mitochondrial protein phosphorylation, carbon flux and metabolic resilience
PDK4 在调节线粒体蛋白磷酸化、碳通量和代谢弹性中的新作用
  • 批准号:
    10604378
  • 财政年份:
    2022
  • 资助金额:
    $ 15.49万
  • 项目类别:
Novel roles of PDK4 in regulating mitochondrial protein phosphorylation, carbon flux and metabolic resilience
PDK4 在调节线粒体蛋白磷酸化、碳通量和代谢弹性中的新作用
  • 批准号:
    10444249
  • 财政年份:
    2022
  • 资助金额:
    $ 15.49万
  • 项目类别:
FASEB Science Research Conference: Protein Kinases and Protein Phosphorylation
FASEB 科学研究会议:蛋白激酶和蛋白磷酸化
  • 批准号:
    10464756
  • 财政年份:
    2022
  • 资助金额:
    $ 15.49万
  • 项目类别:
Protein phosphorylation and Campylobacter jejuni pathogenesis
蛋白质磷酸化和空肠弯曲菌发病机制
  • 批准号:
    10448142
  • 财政年份:
    2022
  • 资助金额:
    $ 15.49万
  • 项目类别:
Determining the effect of RNA binding protein phosphorylation on mRNA fate
确定 RNA 结合蛋白磷酸化对 mRNA 命运的影响
  • 批准号:
    10477945
  • 财政年份:
    2021
  • 资助金额:
    $ 15.49万
  • 项目类别:
Determining the effect of RNA binding protein phosphorylation on mRNA fate
确定 RNA 结合蛋白磷酸化对 mRNA 命运的影响
  • 批准号:
    10680495
  • 财政年份:
    2021
  • 资助金额:
    $ 15.49万
  • 项目类别:
Analysis of Protein Phosphorylation Networks with Designed Kinase and Proteomics
使用设计的激酶和蛋白质组学分析蛋白质磷酸化网络
  • 批准号:
    20K21272
  • 财政年份:
    2020
  • 资助金额:
    $ 15.49万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了